Aurobindo Pharma has received final approval from the US Food and Drug Administration to manufacture and market Oxacillin injections.

Oxacillin injection is sterile semi-synthetic penicillin indicated in the treatment of infections caused by penicillinase producing staphylococci, which have demonstrated susceptibility to the drug.

The product is ready for the launch, the Hyderabad-based company informed the Bombay Stock Exchange on Monday.

>naga.gunturi@thehindu.co.in

comment COMMENT NOW